Emerling BM - Search Results

1

Targeting phosphoinositide signaling in cancer: relevant techniques to study lipids and novel avenues for therapeutic intervention.

Llorente A, Loughran RM, Emerling BM. Llorente A, et al. Among authors: emerling bm. Front Cell Dev Biol. 2023 Oct 25;11:1297355. doi: 10.3389/fcell.2023.1297355. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37954209 Free PMC article.

2

PIP kinases: A versatile family that demands further therapeutic attention.

Llorente A, Arora GK, Grenier SF, Emerling BM. Llorente A, et al. Among authors: emerling bm. Adv Biol Regul. 2023 Jan;87:100939. doi: 10.1016/j.jbior.2022.100939. Epub 2022 Dec 5. Adv Biol Regul. 2023. PMID: 36517396 Free PMC article.

3

Activation of p53-regulated pro-survival signals and hypoxia-independent mitochondrial targeting of TIGAR by human papillomavirus E6 oncoproteins.

Yapindi L, Bowley T, Kurtaneck N, Bergeson RL, James K, Wilbourne J, Harrod CK, Hernandez BY, Emerling BM, Yates C, Harrod R. Yapindi L, et al. Among authors: emerling bm. Virology. 2023 Aug;585:1-20. doi: 10.1016/j.virol.2023.05.004. Epub 2023 May 22. Virology. 2023. PMID: 37257253

4

Hippo and PI5P4K signaling intersect to control the transcriptional activation of YAP.

Palamiuc L, Johnson JL, Haratipour Z, Loughran RM, Choi WJ, Arora GK, Tieu V, Ly K, Llorente A, Crabtree S, Wong JCY, Ravi A, Wiederhold T, Murad R, Blind RD, Emerling BM. Palamiuc L, et al. Among authors: emerling bm. Sci Signal. 2024 May 28;17(838):eado6266. doi: 10.1126/scisignal.ado6266. Epub 2024 May 28. Sci Signal. 2024. PMID: 38805583

5

PI5P4Kα supports prostate cancer metabolism and exposes a survival vulnerability during androgen receptor inhibition.

Triscott J, Reist M, Küng L, Mosele FC, Lehner M, Gallon J, Ravi A, Arora GK, de Brot S, Lundquist M, Gallart-Ayala H, Ivanisevic J, Piscuoglio S, Cantley LC, Emerling BM, Rubin MA. Triscott J, et al. Among authors: emerling bm. Sci Adv. 2023 Feb 3;9(5):eade8641. doi: 10.1126/sciadv.ade8641. Epub 2023 Feb 1. Sci Adv. 2023. PMID: 36724278 Free PMC article.

6

Beyond PI3Ks: targeting phosphoinositide kinases in disease.

Burke JE, Triscott J, Emerling BM, Hammond GRV. Burke JE, et al. Among authors: emerling bm. Nat Rev Drug Discov. 2023 May;22(5):357-386. doi: 10.1038/s41573-022-00582-5. Epub 2022 Nov 14. Nat Rev Drug Discov. 2023. PMID: 36376561 Free PMC article. Review.

7

Endogenous spacing enables co-processing of microRNAs and efficient combinatorial RNAi.

Amen AM, Loughran RM, Huang CH, Lew RJ, Ravi A, Guan Y, Schatoff EM, Dow LE, Emerling BM, Fellmann C. Amen AM, et al. Among authors: emerling bm. Cell Rep Methods. 2022 Jun 21;2(7):100239. doi: 10.1016/j.crmeth.2022.100239. eCollection 2022 Jul 18. Cell Rep Methods. 2022. PMID: 35880017 Free PMC article.

8

Crucial Players for Inter-Organelle Communication: PI5P4Ks and Their Lipid Product PI-4,5-P₂ Come to the Surface.

Ravi A, Palamiuc L, Emerling BM. Ravi A, et al. Among authors: emerling bm. Front Cell Dev Biol. 2022 Jan 7;9:791758. doi: 10.3389/fcell.2021.791758. eCollection 2021. Front Cell Dev Biol. 2022. PMID: 35071233 Free PMC article.

9

Mechanistic roles of mutant p53 governing lipid metabolism.

Loughran RM, Emerling BM. Loughran RM, et al. Among authors: emerling bm. Adv Biol Regul. 2022 Jan;83:100839. doi: 10.1016/j.jbior.2021.100839. Epub 2021 Nov 23. Adv Biol Regul. 2022. PMID: 34840111 Free PMC article. Review.

10

Expanding role of PI5P4Ks in cancer: A promising druggable target.

Arora GK, Palamiuc L, Emerling BM. Arora GK, et al. Among authors: emerling bm. FEBS Lett. 2022 Jan;596(1):3-16. doi: 10.1002/1873-3468.14237. Epub 2021 Dec 7. FEBS Lett. 2022. PMID: 34822164 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page